SCHEMBL4062009

SCHEMBL4062009

Cc1cc(-c2ccc(Cl)s2)[nH]n1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.56
NPSR1 Q6W5P4 1/20 0.56
POLB P06746 7/20 0.46
TNIK Q9UKE5 1/20 0.46
FLT3 P36888 1/20 0.45
MAPT P10636 5/20 0.44
KMT2A Q03164 4/20 0.43
MEN1 O00255 2/20 0.43
TDP1 Q9NUW8 1/20 0.43
ALDH1A1 P00352 2/20 0.42
MAPK1 P28482 1/20 0.42
BLM P54132 1/20 0.41
KDM4E B2RXH2 1/20 0.40
LMNA P02545 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
HTT P42858 1/20 0.40
PGR P06401 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL72067 0.73 L3MBTL1 (0.65) L3MBTL1NPSR1POLBTNIKMAPT
SCHEMBL2053641 0.73 L3MBTL1 (0.47) L3MBTL1NPSR1KMT2AMEN1TDP1
SCHEMBL15374805 0.71 SMN1; SMN2 (0.37) POLBMAPTKMT2AMEN1ALDH1A1
SCHEMBL1594169 0.70 ALDH1A1 (0.45) L3MBTL1NPSR1POLBFLT3MAPT
SCHEMBL21262417 0.70 TNIK (0.74) TNIK
SCHEMBL2875439 0.69 KMT2A (0.57) L3MBTL1POLBFLT3MAPTKMT2A
SCHEMBL70926 0.69 L3MBTL1 (0.58) L3MBTL1NPSR1POLBTNIKMAPT
SCHEMBL3070625 0.68 TRPM8 (0.62) L3MBTL1POLBTNIKMAPTKMT2A
SCHEMBL9048321 0.68 MKNK1 (0.56) NPSR1POLBMAPTKMT2AMEN1
SCHEMBL13066527 0.68 NPSR1 (0.40) L3MBTL1NPSR1POLBTNIKFLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1208097-B1 SUBSTITUTED OXOAZAHETEROCYCLYL COMPOUNDS AVENTIS PHARMA INC (US) 2009-02-18 EP disclosed
CN-1420882-A Substd. oxoazaheterocyclyl compounds AVENTIS PHARM PROD INC (US) 2003-05-28 CN disclosed
EP-1208097-A2 SUBSTITUTED OXOAZAHETEROCYCLYL COMPOUNDS Aventis Pharmaceuticals Inc. (US) 2002-05-29 EP disclosed
WO-2001007436-A2 SUBSTITUTED OXOAZAHETEROCYCLYL COMPOUNDS AVENTIS PHARMACEUTICALS INC. (US) 2001-02-01 WO disclosed